Edward Kim, M.D., Ph.D.
- Associate Professor of Medicine
- Chair, UC Davis Pancreatic Cancer Research Incubator
- Chair, Data and Safety Monitoring Committee, UC Davis Comprehensive Cancer Center
Dr. Kim is an adult medical oncologist who specializes in medical treatment of gastrointestinal malignancies including pancreatic, hepatocellular, biliary, esophageal, gastric, and colorectal cancers.
He has expertise in conducting clinical trials for these malignancies and has a particular interest in novel treatments for pancreatic cancer.
For Gastrointestinal Oncology Clinical Trials at UC Davis Comprehensive Cancer Center, click here.
Dr. Kim’s research includes developing and conducting clinical trials for gastrointestinal malignancies. He has a particular interest in translational and clinical research for pancreatic cancer.
His laboratory research is focused in 2 primary areas: 1) investigation and development of novel rational combinations of drugs for pancreatic cancer, and 2) development of patient-derived models of pancreatic cancer (including patient-derived xenografts and patient-derived organoids) to enhance pre-clinical evaluation of promising new therapeutics for pancreatic cancer.
Hematology and Oncology
M.D., Stony Brook University, Stony Brook NY 2005
Ph.D., Stony Brook University, Stony Brook NY 2003
A.B., Harvard University, Cambridge MA 1997
Internal Medicine, University of Michigan , Ann Arbor MI 2005-2007
Hematology/Oncology, University of Michigan , Ann Arbor MI 2007-2011
American Board of Internal Medicine, 2008
American Board of Internal Medicine, Medical Oncology, 2012
American Association for Canter Research (AACR)
American Society of Clinical Oncology (ASCO)
Southwest Oncology Group (SWOG)
Honors and Awards
NCI Cancer Clinical Team Leadership Award, 2015
ASCO Cancer Foundation Merit Award – GI Cancers Symposium, 2011
Mark Roth Memorial Award, 2010